2 terminated. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Meredith Hawkins: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Diazoxide, Placebo - Diabetes Mellitus, Type 2, Glucose, High Blood | Phase 2 | Terminated | Meredith Hawkins | 37 | 2018-06-12 | 2025-05-31 |
| Central Mechanisms That Regulate Glucose Metabolism in Humans Diazoxide, Placebo - Type 2 Diabetes, Glucose Metabolism Disorders | Phase 4 | Terminated | Meredith Hawkins | 10 | 2006-11-02 | 2025-05-16 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Glucose Metabolism Disorders (2) · Insulin Resistance (1)
Diazoxide (2)
United States (2)
R01DK069861 (2)